Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Applying a specific inhibitor lightens skin and hair color.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

SGK3 is essential for proper hair growth and health.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Targeting EGFR may help reduce hair loss from chemotherapy.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

A 1.0% tyrosine diet increases melanin in chicken feathers.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Removing part of the vitamin D receptor stops vitamin D from working properly.